Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

Investors may react cautiously to news that ABBOTINDIA's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.

Financial Ratios:

currentRatio 2.75500
forwardPE 33.54535
debtToEquity 4.54900
earningsGrowth 0.15800
revenueGrowth 0.07600
grossMargins 0.45773
operatingMargins 0.27518
trailingEps 708.74000
forwardEps 823.06490

The current ratio for ABBOTINDIA is 2.755, indicating that the company can service its short-term debt using available cash and assets. This suggests ABBOTINDIA has strong liquidity, with more than enough resources to meet its immediate financial commitments.
Positive gross and operating margins for ABBOTINDIA demonstrate the company's profitability. These margins reflect strong financial performance, with efficient operations contributing to the company's ability to generate consistent profits.
ABBOTINDIA's forward EPS is higher than its trailing EPS, suggesting the company is expected to see an increase in profitability this year. This points to positive growth, indicating that ABBOTINDIA is projected to improve its financial performance compared to the previous year.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

ABBOTINDIA's price has often been near the lower end of the projected range. This ongoing trend suggests that investor confidence might be waning, and the stock could face challenges in gaining upward momentum.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Abbott India Limited has garnered a buy bias from analysts recently, suggesting the stock is a good investment opportunity. This may lead to increased investor interest, as Abbott India Limited is seen as a reliable place to park money for those looking to benefit from potential market gains and company growth.